All In Biotech

Drug Trial Radar · NCT06367283

Metformin Treatment of Patients with Hand Osteoarthritis

Metformin Treatment of Patients with Hand Osteoarthritis: a Randomised, Placebo-controlled Trial

Last checked: Nov 20, 2026Latest source record: Feb 27, 2025 (this record)Source: ClinicalTrials.govMethods & limitations

RecruitingPivotal-lookingPhase 3. Randomized with 150 participants. This is a heuristic, not a regulatory label.

Status

Recruiting

Enrollment

150

Planned (sponsor's estimate)

Start

Jun 3, 2024

Primary completion

Dec 2025

Study completion Apr 2026

Sponsor

Lead sponsor
Marius HenriksenAcademic, hospital or other
Sponsor type
Academic, hospital or other
First posted
Apr 16, 2024

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 3
Allocation
Randomized
Model
Parallel
Masking
Quadruple (participant, care provider, investigator, outcomes assessor)
Primary purpose
Treatment
FDA-regulated drug
Yes
Who can join
All sexes, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

To compare metformin (2 g daily), or maximum tolerated dose, for 16 weeks with placebo as a treatment of hand osteoarthritis symptoms.

Conditions

  • Hand Osteoarthritis

Interventions

  • MetforminDrug

    Metformin will be initiated at 500 mg once daily with breakfast meal. The dose will be increased with 500 mg every week until 2 g/day is reached, distributed as 1000 mg every morning and evening, together with a meal. If the subject cannot tolerate the maximum dose (2 g/day), the maximal tolerated dose will be given. The treatment period including titration is 16 weeks.

  • PlaceboDrug

    Participants in the placebo group will receive a placebo tablet identical to the metformin tablet

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Finger painTime frame: Week 16

Locations

1 site in 1 country. Site status is shown where the registry gives one.

  • The Parker Institute, Bispebjerg and Frederiksberg hospital

    Copenhagen, Frederiksberg, Denmark · Recruiting

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.